These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32783391)

  • 21. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
    Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP
    Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.
    Pasha HF; Tantawy EA; Youssef MA
    Gene; 2019 Jun; 702():107-113. PubMed ID: 30898714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus.
    Huang HT; Chen JM; Guo J; Lan Y; Wei YS
    Rheumatol Int; 2016 Jun; 36(6):799-805. PubMed ID: 26769434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms of IL-27 and risk of systemic lupus erythematosus disease in the Egyptian population.
    Ali YBM; El-Akhras BA; El-Shazly R; Bassyouni IH
    Clin Rheumatol; 2021 Dec; 40(12):4899-4907. PubMed ID: 34324143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.
    Clancy R; El Bannoudi H; Rasmussen SE; Bornkamp N; Allen N; Dann R; Reynolds H; Buyon JP; Berger JS
    J Thromb Haemost; 2019 Mar; 17(3):532-537. PubMed ID: 30638300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmed cell death 1 gene polymorphism as a possible risk for systemic lupus erythematosus in Egyptian females.
    Abo El-Khair SM; Sameer W; Awadallah N; Shaalan D
    Lupus; 2019 Oct; 28(12):1427-1434. PubMed ID: 31551030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Serum β2-microglobulin in Egyptian Patients with Systemic Lupus Erythematosus.
    Abd-Elbaky NM; Albeltagy ES; Hammour AE; Ibrahim AS
    Egypt J Immunol; 2019 Jul; 26(2):143-153. PubMed ID: 31926503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematocrit Level could Reflect Inflammatory Response and Disease Activity in Patients with Systemic Lupus Erythematosus.
    Yang M; Ma N; Fu H; Wei T; Tang Q; Qin B; Yang Z; Zhong R
    Clin Lab; 2015; 61(7):801-7. PubMed ID: 26299080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus.
    Motawi TK; Mohsen DA; El-Maraghy SA; Kortam MA
    Chem Biol Interact; 2016 Dec; 260():110-116. PubMed ID: 27816459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the IL-17F, IL-23 and IL-23R on susceptibility and phenotype of systemic lupus erythematosus.
    Paradowska-Gorycka A; Sowinska A; Stypinska B; Grobelna MK; Walczyk M; Olesinska M; Piotrowski P; Jagodziński PP
    Autoimmunity; 2016 Sep; 49(6):373-382. PubMed ID: 27320770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 polymorphisms with systemic lupus erythematosus disease activity and biomarker levels: A case-control study in Chinese population.
    Su Z; Niu Q; Huang Z; Yang B; Zhang J
    Medicine (Baltimore); 2020 Aug; 99(35):e21888. PubMed ID: 32871918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of interleukin-17A gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multi-centre study.
    Elkoumi MA; Allah MA; Mohamed FY; Boraey NF; Abdellatif SH; Shehab MM; Sherif AH; Akeel NE; Saleh RM; Elshreif AM; Abdelrahman HM; Soliman AA; Emam AA; Youssef MA; Fahmy DS; Sallam MM; Nawara AM; Elgohary EA; Ismael A; El-Kaffas SM; Sobeih AA; Ibrahim LM; Ibrahim MA; Abdou AM; Yousry SM; Osman SF; El-Deeb FM; Elhewala AA; Hafez SF; Waked NM; Elbasyouni HA; Fouad RA; Zeidan NM; Nashat M; Farghaly MA
    Lupus; 2020 Jun; 29(7):767-775. PubMed ID: 32380889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus activity and beta two microglobulin levels.
    Skare TL; Ferri K; Santos MA
    Sao Paulo Med J; 2014; 132(4):239-42. PubMed ID: 25055070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus.
    Lan Y; Luo B; Wang JL; Jiang YW; Wei YS
    Gene; 2014 Mar; 538(1):94-8. PubMed ID: 24434811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients.
    El-Karaksy SM; Kholoussi NM; Shahin RM; El-Ghar MM; Gheith Rel-S
    Gene; 2013 Sep; 527(1):211-4. PubMed ID: 23792015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL; Jones AC; Brown NS; Powell RJ
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus.
    Abbas D; Ezzat Y; Hamdy E; Gamil M
    Lupus; 2012 Jan; 21(1):103-10. PubMed ID: 21976404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
    Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
    Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.
    Park YB; Lee SK; Kim DS; Lee J; Lee CH; Song CH
    Clin Exp Rheumatol; 1998; 16(3):283-8. PubMed ID: 9631750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.